Currently out of the existing stock ratings of Sumeet Mody, 58 are a BUY (81.69%), 12 are a HOLD (16.9%), 1 are a SELL (1.41%).

Sumeet Mody

Work Performance Price Targets & Ratings Chart

Analyst Sumeet Mody, carries an average stock price target met ratio of 82.2% that have a potential upside of 42.17% achieved within 361 days. Previously, Sumeet Mody worked at PIPER SANDLER.

Sumeet Mody’s has documented 142 price targets and ratings displayed on 13 stocks. The coverage was on Financial Services, Technology sectors.

Most recent stock forecast was given on ENFN, Enfusion at 23-Dec-2024.

Wall Street Analyst Sumeet Mody

Analyst best performing recommendations are on OWL (BLUE OWL CAPITAL).
The best stock recommendation documented was for VRTS (VIRTUS INVESTMENT PARTNERS) at 10/15/2020. The price target of $200 was fulfilled within 117 days with a profit of $69.38 (53.12%) receiving and performance score of 4.54.

Average potential price target upside

ARES Ares Management LP BX Blackstone Group CG Carlyle Group KKR KKR LP SAMG Silvercrest Asset Management Group VCTR Victory Capital Holdings VRTS Virtus Investment Partners PJT PJT Partners COWN Cowen Group OWL Blue Owl Capital ENFN Enfusion GCMG GCM Grosvenor SEIC SEI Investments Company

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-Apr-2025

$162

$44.78 (38.20%)

$151

1 months 16 days ago
(27-Aug-2026)

4/8 (50%)

$21.08 (14.96%)

67

Buy Since 24-Feb-2026

$168

$50.78 (43.32%)

$162

2 months 10 days ago
(03-Aug-2026)

0/3 (0%)

$30.88 (22.52%)

Buy Since 07-Jun-2024

$155

$37.78 (32.23%)

$153

2 months 10 days ago
(03-Aug-2026)

7/19 (36.84%)

$17.88 (13.04%)

108

Hold Since 02-Oct-2025

$134

$16.78 (14.31%)

$128

2 months 10 days ago
(03-Aug-2026)

6/7 (85.71%)

$-3.12 (-2.28%)

55

Buy Since 02-Aug-2023

$153

$35.78 (30.52%)

$144

2 months 10 days ago
(03-Aug-2026)

5/6 (83.33%)

$15.88 (11.58%)

110

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?